Search

Your search keyword '"Orfao A"' showing total 4,859 results

Search Constraints

Start Over You searched for: Author "Orfao A" Remove constraint Author: "Orfao A" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
4,859 results on '"Orfao A"'

Search Results

1. Cytochrome P450-soluble epoxide hydrolase derived linoleic acid oxylipins and cognitive performance in type 2 diabetes.

3. Developing Digital Forensics Expertise Competencies Through Courtroom Role-Play

4. Analysis of Generative Data Augmentation for Face Antispoofing

5. Contribution of copy number to improve risk stratification of adult T-cell acute lymphoblastic leukemia patients enrolled in measurable residual disease-oriented trials

6. Cytochrome P450-soluble epoxide hydrolase oxylipins, depression and cognition in type 2 diabetes

7. Immunophenotypic assessment of clonal plasma cells and B-cells in bone marrow and blood in the diagnostic classification of early stage monoclonal gammopathies: an iSTOPMM study

8. Determining hemodilution in diagnostic bone marrow aspirated samples in plasma cell disorders by next-generation flow cytometry: Proposal for a bone marrow quality index

9. Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance

10. Baseline immunophenotypic profile of bone marrow leukemia cells in acute myeloid leukemia with nucleophosmin-1 gene mutation: a EuroFlow study

11. Immune stress suppresses innate immune signaling in preleukemic precursor B-cells to provoke leukemia in predisposed mice

14. Harmonization of Diagnostic Criteria in Mastocytosis for Use in Clinical Practice: WHO vs ICC vs AIM/ECNM

15. Crimean-Congo Hemorrhagic Fever, Spain, 2013-2021

16. Reverse-bias current hysteresis at low temperature in GaN Schottky barrier diodes.

19. The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT

20. Acute myeloid leukemia of donor origin after allogeneic stem cell transplantation from a sibling who harbors germline XPD and XRCC3 homozygous polymorphisms

22. European Competence Network on Mastocytosis (ECNM): 20-Year Jubilee, Updates, and Future Perspectives

24. Interlaboratory Analytical Validation of a Next-Generation Sequencing Strategy for Clonotypic Assessment and Minimal Residual Disease Monitoring in Multiple Myeloma

25. Tγδ LGLL identifies a subset with more symptomatic disease: analysis of an international cohort of 137 patients

27. Automated identification of leukocyte subsets improves standardization of database-guided expert-supervised diagnostic orientation in acute leukemia: a EuroFlow study

28. The Role of Alternative Medicine in Managing Type 2 Diabetes: A Comprehensive Review

29. 170 Celiac disease in selective IgA deficiency patients is associated with T-cell defects

30. 174 Age-associated distribution of TH subsets in blood of LOCID vs CVID patients

32. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

33. Afección pericárdica y miocárdica tras infección por SARS-CoV-2: estudio descriptivo transversal en trabajadores sanitarios

34. Mast Cell Diseases in Practice and Research: Issues and Perspectives Raised by Patients and Their Recommendations to the Scientific Community and Beyond

35. Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM Consortium

36. Standards of Pathology in the Diagnosis of Systemic Mastocytosis: Recommendations of the EU-US Cooperative Group

37. Proposed European Competence Network on Mastocytosis—American Initiative in Mast Cell Diseases (ECNM-AIM) Response Criteria in Advanced Systemic Mastocytosis

38. Global Classification of Mast Cell Activation Disorders: An ICD-10-CM–Adjusted Proposal of the ECNM-AIM Consortium

39. Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User’s Guide for Daily Clinical Practice

40. Standards of Genetic Testing in the Diagnosis and Prognostication of Systemic Mastocytosis in 2022: Recommendations of the EU-US Cooperative Group

41. CD34+CD19−CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies

42. Comprehensive and systematic characterization of multi-functionalized cisplatin nano-conjugate: from the chemistry and proteomic biocompatibility to the animal model

44. A Comparison of Computer Vision Methods for the Combined Detection of Glaucoma, Diabetic Retinopathy and Cataracts

45. Expert-independent classification of mature B-cell neoplasms using standardized flow cytometry: a multicentric study

46. Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies

48. Multiple jobholding and non-standard employment among young workers: a comparative analysis of EU-28 member states.

49. A novel NKp80-based strategy for universal identification of normal, reactive and tumor/clonal natural killer-cells in blood.

50. T‐cell immune profile in blood of systemic mastocytosis: Association with disease features.

Catalog

Books, media, physical & digital resources